カテゴリー： 世界, 医療/バイオ, QYResearch

血管収縮薬の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Vasoconstrictor Drugs Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09302）・商品コード：QY22JLX09302
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：114
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、血管収縮薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に血管収縮薬の世界市場のxxx％を占める「錠剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
血管収縮薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの血管収縮薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

血管収縮薬のグローバル主要企業には、Pfizer、Fresenius Kabi、Par Pharmaceutical、Ferring B.V.、Endo International、Astellas Pharma、Hybio Pharmaceutical、Cumberland Pharmaceuticals、AstraZeneca、Novartis、Bayer、Shanghai Soho-Yiming Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

血管収縮薬市場は、種類と用途によって区分されます。世界の血管収縮薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
錠剤、注射剤、その他

【用途別セグメント】
病院薬局、小売薬局、オンライン薬局

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 血管収縮薬製品概要
- 種類別市場（錠剤、注射剤、その他）
- 用途別市場（病院薬局、小売薬局、オンライン薬局）
- 調査の目的
・エグゼクティブサマリー
- 世界の血管収縮薬販売量予測2017-2028
- 世界の血管収縮薬売上予測2017-2028
- 血管収縮薬の地域別販売量
- 血管収縮薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別血管収縮薬販売量
- 主要メーカー別血管収縮薬売上
- 主要メーカー別血管収縮薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（錠剤、注射剤、その他）
- 血管収縮薬の種類別販売量
- 血管収縮薬の種類別売上
- 血管収縮薬の種類別価格
・用途別市場規模（病院薬局、小売薬局、オンライン薬局）
- 血管収縮薬の用途別販売量
- 血管収縮薬の用途別売上
- 血管収縮薬の用途別価格
・北米市場
- 北米の血管収縮薬市場規模（種類別、用途別）
- 主要国別の血管収縮薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの血管収縮薬市場規模（種類別、用途別）
- 主要国別の血管収縮薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の血管収縮薬市場規模（種類別、用途別）
- 主要国別の血管収縮薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の血管収縮薬市場規模（種類別、用途別）
- 主要国別の血管収縮薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの血管収縮薬市場規模（種類別、用途別）
- 主要国別の血管収縮薬市場規模（トルコ、サウジアラビア）
・企業情報
Pfizer、Fresenius Kabi、Par Pharmaceutical、Ferring B.V.、Endo International、Astellas Pharma、Hybio Pharmaceutical、Cumberland Pharmaceuticals、AstraZeneca、Novartis、Bayer、Shanghai Soho-Yiming Pharmaceuticals
・産業チェーン及び販売チャネル分析
- 血管収縮薬の産業チェーン分析
- 血管収縮薬の原材料
- 血管収縮薬の生産プロセス
- 血管収縮薬の販売及びマーケティング
- 血管収縮薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 血管収縮薬の産業動向
- 血管収縮薬のマーケットドライバー
- 血管収縮薬の課題
- 血管収縮薬の阻害要因
・主な調査結果

Vasoconstrictor medicines belong to a class of drugs known as pressor drugs because they raise arterial pressure. These medications induce blood vessels to constrict by contracting the smooth muscle in the vessels. Because mean arterial pressure is determined by the product of systemic vascular resistance and cardiac output, constriction of arterial vessels raises systemic vascular resistance, which leads to a rise in arterial blood pressure. The Frank-Starling mechanism, which increases arterial pressure, increases venous blood pressure and increases cardiac preload and cardiac output when venous arteries are constricted.
Market Analysis and Insights: Global Vasoconstrictor Drugs Market
The global Vasoconstrictor Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Tablet accounting for % of the Vasoconstrictor Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Vasoconstrictor Drugs market size is valued at US$ million in 2021, while the North America and Europe Vasoconstrictor Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Vasoconstrictor Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vasoconstrictor Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vasoconstrictor Drugs market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vasoconstrictor Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vasoconstrictor Drugs market.
Global Vasoconstrictor Drugs Scope and Market Size
Vasoconstrictor Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Vasoconstrictor Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tablet
Injection
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Company
Pfizer
Fresenius Kabi
Par Pharmaceutical
Ferring B.V.
Endo International
Astellas Pharma
Hybio Pharmaceutical
Cumberland Pharmaceuticals
AstraZeneca
Novartis
Bayer
Shanghai Soho-Yiming Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vasoconstrictor Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablet
1.2.3 Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Vasoconstrictor Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vasoconstrictor Drugs Market Perspective (2017-2028)
2.2 Vasoconstrictor Drugs Growth Trends by Region
2.2.1 Vasoconstrictor Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Vasoconstrictor Drugs Historic Market Size by Region (2017-2022)
2.2.3 Vasoconstrictor Drugs Forecasted Market Size by Region (2023-2028)
2.3 Vasoconstrictor Drugs Market Dynamics
2.3.1 Vasoconstrictor Drugs Industry Trends
2.3.2 Vasoconstrictor Drugs Market Drivers
2.3.3 Vasoconstrictor Drugs Market Challenges
2.3.4 Vasoconstrictor Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vasoconstrictor Drugs Players by Revenue
3.1.1 Global Top Vasoconstrictor Drugs Players by Revenue (2017-2022)
3.1.2 Global Vasoconstrictor Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Vasoconstrictor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vasoconstrictor Drugs Revenue
3.4 Global Vasoconstrictor Drugs Market Concentration Ratio
3.4.1 Global Vasoconstrictor Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vasoconstrictor Drugs Revenue in 2021
3.5 Vasoconstrictor Drugs Key Players Head office and Area Served
3.6 Key Players Vasoconstrictor Drugs Product Solution and Service
3.7 Date of Enter into Vasoconstrictor Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vasoconstrictor Drugs Breakdown Data by Type
4.1 Global Vasoconstrictor Drugs Historic Market Size by Type (2017-2022)
4.2 Global Vasoconstrictor Drugs Forecasted Market Size by Type (2023-2028)
5 Vasoconstrictor Drugs Breakdown Data by Application
5.1 Global Vasoconstrictor Drugs Historic Market Size by Application (2017-2022)
5.2 Global Vasoconstrictor Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Vasoconstrictor Drugs Market Size (2017-2028)
6.2 North America Vasoconstrictor Drugs Market Size by Type
6.2.1 North America Vasoconstrictor Drugs Market Size by Type (2017-2022)
6.2.2 North America Vasoconstrictor Drugs Market Size by Type (2023-2028)
6.2.3 North America Vasoconstrictor Drugs Market Share by Type (2017-2028)
6.3 North America Vasoconstrictor Drugs Market Size by Application
6.3.1 North America Vasoconstrictor Drugs Market Size by Application (2017-2022)
6.3.2 North America Vasoconstrictor Drugs Market Size by Application (2023-2028)
6.3.3 North America Vasoconstrictor Drugs Market Share by Application (2017-2028)
6.4 North America Vasoconstrictor Drugs Market Size by Country
6.4.1 North America Vasoconstrictor Drugs Market Size by Country (2017-2022)
6.4.2 North America Vasoconstrictor Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Vasoconstrictor Drugs Market Size (2017-2028)
7.2 Europe Vasoconstrictor Drugs Market Size by Type
7.2.1 Europe Vasoconstrictor Drugs Market Size by Type (2017-2022)
7.2.2 Europe Vasoconstrictor Drugs Market Size by Type (2023-2028)
7.2.3 Europe Vasoconstrictor Drugs Market Share by Type (2017-2028)
7.3 Europe Vasoconstrictor Drugs Market Size by Application
7.3.1 Europe Vasoconstrictor Drugs Market Size by Application (2017-2022)
7.3.2 Europe Vasoconstrictor Drugs Market Size by Application (2023-2028)
7.3.3 Europe Vasoconstrictor Drugs Market Share by Application (2017-2028)
7.4 Europe Vasoconstrictor Drugs Market Size by Country
7.4.1 Europe Vasoconstrictor Drugs Market Size by Country (2017-2022)
7.4.2 Europe Vasoconstrictor Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vasoconstrictor Drugs Market Size (2017-2028)
8.2 Asia-Pacific Vasoconstrictor Drugs Market Size by Type
8.2.1 Asia-Pacific Vasoconstrictor Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Vasoconstrictor Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Vasoconstrictor Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Vasoconstrictor Drugs Market Size by Application
8.3.1 Asia-Pacific Vasoconstrictor Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Vasoconstrictor Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Vasoconstrictor Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Vasoconstrictor Drugs Market Size by Region
8.4.1 Asia-Pacific Vasoconstrictor Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Vasoconstrictor Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Vasoconstrictor Drugs Market Size (2017-2028)
9.2 Latin America Vasoconstrictor Drugs Market Size by Type
9.2.1 Latin America Vasoconstrictor Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Vasoconstrictor Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Vasoconstrictor Drugs Market Share by Type (2017-2028)
9.3 Latin America Vasoconstrictor Drugs Market Size by Application
9.3.1 Latin America Vasoconstrictor Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Vasoconstrictor Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Vasoconstrictor Drugs Market Share by Application (2017-2028)
9.4 Latin America Vasoconstrictor Drugs Market Size by Country
9.4.1 Latin America Vasoconstrictor Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Vasoconstrictor Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vasoconstrictor Drugs Market Size (2017-2028)
10.2 Middle East & Africa Vasoconstrictor Drugs Market Size by Type
10.2.1 Middle East & Africa Vasoconstrictor Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Vasoconstrictor Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Vasoconstrictor Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Vasoconstrictor Drugs Market Size by Application
10.3.1 Middle East & Africa Vasoconstrictor Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Vasoconstrictor Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Vasoconstrictor Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Vasoconstrictor Drugs Market Size by Country
10.4.1 Middle East & Africa Vasoconstrictor Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Vasoconstrictor Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Vasoconstrictor Drugs Introduction
11.1.4 Pfizer Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Company Details
11.2.2 Fresenius Kabi Business Overview
11.2.3 Fresenius Kabi Vasoconstrictor Drugs Introduction
11.2.4 Fresenius Kabi Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.2.5 Fresenius Kabi Recent Developments
11.3 Par Pharmaceutical
11.3.1 Par Pharmaceutical Company Details
11.3.2 Par Pharmaceutical Business Overview
11.3.3 Par Pharmaceutical Vasoconstrictor Drugs Introduction
11.3.4 Par Pharmaceutical Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.3.5 Par Pharmaceutical Recent Developments
11.4 Ferring B.V.
11.4.1 Ferring B.V. Company Details
11.4.2 Ferring B.V. Business Overview
11.4.3 Ferring B.V. Vasoconstrictor Drugs Introduction
11.4.4 Ferring B.V. Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.4.5 Ferring B.V. Recent Developments
11.5 Endo International
11.5.1 Endo International Company Details
11.5.2 Endo International Business Overview
11.5.3 Endo International Vasoconstrictor Drugs Introduction
11.5.4 Endo International Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.5.5 Endo International Recent Developments
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Vasoconstrictor Drugs Introduction
11.6.4 Astellas Pharma Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.6.5 Astellas Pharma Recent Developments
11.7 Hybio Pharmaceutical
11.7.1 Hybio Pharmaceutical Company Details
11.7.2 Hybio Pharmaceutical Business Overview
11.7.3 Hybio Pharmaceutical Vasoconstrictor Drugs Introduction
11.7.4 Hybio Pharmaceutical Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.7.5 Hybio Pharmaceutical Recent Developments
11.8 Cumberland Pharmaceuticals
11.8.1 Cumberland Pharmaceuticals Company Details
11.8.2 Cumberland Pharmaceuticals Business Overview
11.8.3 Cumberland Pharmaceuticals Vasoconstrictor Drugs Introduction
11.8.4 Cumberland Pharmaceuticals Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.8.5 Cumberland Pharmaceuticals Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Vasoconstrictor Drugs Introduction
11.9.4 AstraZeneca Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.9.5 AstraZeneca Recent Developments
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Vasoconstrictor Drugs Introduction
11.10.4 Novartis Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.10.5 Novartis Recent Developments
11.11 Bayer
11.11.1 Bayer Company Details
11.11.2 Bayer Business Overview
11.11.3 Bayer Vasoconstrictor Drugs Introduction
11.11.4 Bayer Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.11.5 Bayer Recent Developments
11.12 Shanghai Soho-Yiming Pharmaceuticals
11.12.1 Shanghai Soho-Yiming Pharmaceuticals Company Details
11.12.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
11.12.3 Shanghai Soho-Yiming Pharmaceuticals Vasoconstrictor Drugs Introduction
11.12.4 Shanghai Soho-Yiming Pharmaceuticals Revenue in Vasoconstrictor Drugs Business (2017-2022)
11.12.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Vasoconstrictor Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Tablet
Table 3. Key Players of Injection
Table 4. Key Players of Others
Table 5. Global Vasoconstrictor Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Vasoconstrictor Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Vasoconstrictor Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Vasoconstrictor Drugs Market Share by Region (2017-2022)
Table 9. Global Vasoconstrictor Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Vasoconstrictor Drugs Market Share by Region (2023-2028)
Table 11. Vasoconstrictor Drugs Market Trends
Table 12. Vasoconstrictor Drugs Market Drivers
Table 13. Vasoconstrictor Drugs Market Challenges
Table 14. Vasoconstrictor Drugs Market Restraints
Table 15. Global Vasoconstrictor Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Vasoconstrictor Drugs Revenue Share by Players (2017-2022)
Table 17. Global Top Vasoconstrictor Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasoconstrictor Drugs as of 2021)
Table 18. Ranking of Global Top Vasoconstrictor Drugs Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Vasoconstrictor Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Vasoconstrictor Drugs Product Solution and Service
Table 22. Date of Enter into Vasoconstrictor Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Vasoconstrictor Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Vasoconstrictor Drugs Revenue Market Share by Type (2017-2022)
Table 26. Global Vasoconstrictor Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Vasoconstrictor Drugs Revenue Market Share by Type (2023-2028)
Table 28. Global Vasoconstrictor Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Vasoconstrictor Drugs Revenue Share by Application (2017-2022)
Table 30. Global Vasoconstrictor Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Vasoconstrictor Drugs Revenue Share by Application (2023-2028)
Table 32. North America Vasoconstrictor Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Vasoconstrictor Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Vasoconstrictor Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Vasoconstrictor Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Vasoconstrictor Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Vasoconstrictor Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Vasoconstrictor Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Vasoconstrictor Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Vasoconstrictor Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Vasoconstrictor Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Vasoconstrictor Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Vasoconstrictor Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Vasoconstrictor Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Vasoconstrictor Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Vasoconstrictor Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Vasoconstrictor Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Vasoconstrictor Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Vasoconstrictor Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Vasoconstrictor Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Vasoconstrictor Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Vasoconstrictor Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Vasoconstrictor Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Vasoconstrictor Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Vasoconstrictor Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Vasoconstrictor Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Vasoconstrictor Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Vasoconstrictor Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Vasoconstrictor Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Vasoconstrictor Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Vasoconstrictor Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Vasoconstrictor Drugs Product
Table 65. Pfizer Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 66. Pfizer Recent Developments
Table 67. Fresenius Kabi Company Details
Table 68. Fresenius Kabi Business Overview
Table 69. Fresenius Kabi Vasoconstrictor Drugs Product
Table 70. Fresenius Kabi Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 71. Fresenius Kabi Recent Developments
Table 72. Par Pharmaceutical Company Details
Table 73. Par Pharmaceutical Business Overview
Table 74. Par Pharmaceutical Vasoconstrictor Drugs Product
Table 75. Par Pharmaceutical Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 76. Par Pharmaceutical Recent Developments
Table 77. Ferring B.V. Company Details
Table 78. Ferring B.V. Business Overview
Table 79. Ferring B.V. Vasoconstrictor Drugs Product
Table 80. Ferring B.V. Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 81. Ferring B.V. Recent Developments
Table 82. Endo International Company Details
Table 83. Endo International Business Overview
Table 84. Endo International Vasoconstrictor Drugs Product
Table 85. Endo International Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 86. Endo International Recent Developments
Table 87. Astellas Pharma Company Details
Table 88. Astellas Pharma Business Overview
Table 89. Astellas Pharma Vasoconstrictor Drugs Product
Table 90. Astellas Pharma Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 91. Astellas Pharma Recent Developments
Table 92. Hybio Pharmaceutical Company Details
Table 93. Hybio Pharmaceutical Business Overview
Table 94. Hybio Pharmaceutical Vasoconstrictor Drugs Product
Table 95. Hybio Pharmaceutical Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 96. Hybio Pharmaceutical Recent Developments
Table 97. Cumberland Pharmaceuticals Company Details
Table 98. Cumberland Pharmaceuticals Business Overview
Table 99. Cumberland Pharmaceuticals Vasoconstrictor Drugs Product
Table 100. Cumberland Pharmaceuticals Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 101. Cumberland Pharmaceuticals Recent Developments
Table 102. AstraZeneca Company Details
Table 103. AstraZeneca Business Overview
Table 104. AstraZeneca Vasoconstrictor Drugs Product
Table 105. AstraZeneca Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 106. AstraZeneca Recent Developments
Table 107. Novartis Company Details
Table 108. Novartis Business Overview
Table 109. Novartis Vasoconstrictor Drugs Product
Table 110. Novartis Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 111. Novartis Recent Developments
Table 112. Bayer Company Details
Table 113. Bayer Business Overview
Table 114. Bayer Vasoconstrictor Drugs Product
Table 115. Bayer Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 116. Bayer Recent Developments
Table 117. Shanghai Soho-Yiming Pharmaceuticals Company Details
Table 118. Shanghai Soho-Yiming Pharmaceuticals Business Overview
Table 119. Shanghai Soho-Yiming Pharmaceuticals Vasoconstrictor Drugs Product
Table 120. Shanghai Soho-Yiming Pharmaceuticals Revenue in Vasoconstrictor Drugs Business (2017-2022) & (US$ Million)
Table 121. Shanghai Soho-Yiming Pharmaceuticals Recent Developments
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vasoconstrictor Drugs Market Share by Type: 2021 VS 2028
Figure 2. Tablet Features
Figure 3. Injection Features
Figure 4. Others Features
Figure 5. Global Vasoconstrictor Drugs Market Share by Application: 2021 VS 2028
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Vasoconstrictor Drugs Report Years Considered
Figure 10. Global Vasoconstrictor Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Vasoconstrictor Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Vasoconstrictor Drugs Market Share by Region: 2021 VS 2028
Figure 13. Global Vasoconstrictor Drugs Market Share by Players in 2021
Figure 14. Global Top Vasoconstrictor Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasoconstrictor Drugs as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Vasoconstrictor Drugs Revenue in 2021
Figure 16. North America Vasoconstrictor Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Vasoconstrictor Drugs Market Size Market Share by Type (2017-2028)
Figure 18. North America Vasoconstrictor Drugs Market Size Market Share by Application (2017-2028)
Figure 19. North America Vasoconstrictor Drugs Market Size Share by Country (2017-2028)
Figure 20. United States Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Vasoconstrictor Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Vasoconstrictor Drugs Market Size Market Share by Type (2017-2028)
Figure 24. Europe Vasoconstrictor Drugs Market Size Market Share by Application (2017-2028)
Figure 25. Europe Vasoconstrictor Drugs Market Size Share by Country (2017-2028)
Figure 26. Germany Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Vasoconstrictor Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Vasoconstrictor Drugs Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Vasoconstrictor Drugs Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Vasoconstrictor Drugs Market Size Share by Region (2017-2028)
Figure 36. China Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Vasoconstrictor Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Vasoconstrictor Drugs Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Vasoconstrictor Drugs Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Vasoconstrictor Drugs Market Size Share by Country (2017-2028)
Figure 46. Mexico Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Vasoconstrictor Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Vasoconstrictor Drugs Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Vasoconstrictor Drugs Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Vasoconstrictor Drugs Market Size Share by Country (2017-2028)
Figure 52. Turkey Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Vasoconstrictor Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Pfizer Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 56. Fresenius Kabi Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 57. Par Pharmaceutical Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 58. Ferring B.V. Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 59. Endo International Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 60. Astellas Pharma Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 61. Hybio Pharmaceutical Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 62. Cumberland Pharmaceuticals Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 63. AstraZeneca Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 64. Novartis Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 65. Bayer Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 66. Shanghai Soho-Yiming Pharmaceuticals Revenue Growth Rate in Vasoconstrictor Drugs Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed


★調査レポート[血管収縮薬の世界市場インサイト・予測（～2028年）] (コード：QY22JLX09302)販売に関する免責事項を必ずご確認ください。
★調査レポート[血管収縮薬の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • オラパリブ薬の世界市場インサイト・予測（～2028年）
  • 新型コロナウイルス感染症小分子薬の世界市場インサイト・予測（～2028年）
  • アレルギー治療薬の世界市場インサイト・予測（～2028年）
  • 代謝性疾患治療薬の世界市場インサイト・予測（～2028年）
  • 免疫抑制薬の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆